← Retour au Screener

Sector: Santé
Open in Terminal → ATRLive chart · Key metrics · News · Smart money

AptarGroup, Inc.

ATR Mid Cap

Healthcare · Medical Instruments & Supplies

Mis à jour: Jun 18, 2026, 22:21 UTC

104,97 €
+0.25% aujourd'hui
52W: 90,09 € – 143,36 €
52W Low: 90,09 € Position: 27.9% 52W High: 143,36 €

Price Chart

Indicateurs clés

P/E Ratio
20.6x
Cours/Bénéfice
Forward P/E
19.18x
P/E prévisionnel
P/S Ratio
1.98x
Cours/Ventes
EV/EBITDA
11.1x
Valeur d'entreprise/EBITDA
Rend. dividende
1.57%
Rendement annuel du dividende
Cap. boursière
6,7 Md €
Capitalisation boursière
Croissance du CA
10.8%
Croissance du CA sur un an
Marge bénéficiaire
9.98%
Marge nette
ROE
14.8%
Rentabilité des capitaux propres
Beta
0.4
Sensibilité au marché
Positions vendeuses
3.22%
% du flottant vendu à découvert
Volume moyen
512,336
Volume quotidien moyen

Valuation Analysis

Signal
Fair
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Acheter
7 analysts
Avg. Price Target
140,00 €
+33.37% upside
Target Range
122,17 € – 191,99 €

About the Company

Sector: Healthcare Industry: Medical Instruments & Supplies Country: United States Employees: 14,000 Exchange: NYQ

AptarGroup, Inc. en bref

AptarGroup, Inc. (ATR) is currently trading at 104,97 € with a market capitalization of 6,7 Md €. The trailing P/E ratio stands at 20.6x, with a forward P/E of 19.18x. The 52-week range spans from 90,09 € to 143,36 €; the current price is 26.8% below the yearly high. Year-over-year revenue growth stands at +10.8%. The net profit margin stands at 9.98%.

💰 Dividende

AptarGroup, Inc. pays an annual dividend of 1,65 € per share, representing a yield of 1.57%. The payout ratio stands at 31.85%.

📊 Avis des analystes

7 analystes évaluent AptarGroup, Inc. (ATR) au consensus : Acheter. L'objectif de cours moyen est de 140,00 €, soit un potentiel de +33.37% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 122,17 € à 191,99 €.

AptarGroup, Inc. : la thèse d'investissement en détail

AptarGroup, Inc. (ATR) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 10.8% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Wall Street consensus sits at Buy with an average price target implying roughly 33.37% upside from current levels — analyst sentiment is firmly constructive.

À surveiller

  • The analyst consensus price target implies 33.37% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Points forts
  • Consensus des analystes : Buy
  • Free cash flow positif
Points faibles

Aucun signal d'alerte significatif dans les indicateurs actuels.

Aperçu technique

MM 50 jours
105,29 €
-0.3% vs. cours
MM 200 jours
110,06 €
-4.62% vs. cours
Sous le plus haut 52s
−26.8%
143,36 €
Au-dessus du plus bas 52s
+16.5%
90,09 €

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

Risque de marché (Bêta)
0.4 · Défensive
Évolue moins que le marché global
Positions vendeuses
3.22% · Faible
% du flottant vendu à découvert
Dette/Capitaux propres
53.72 · Modéré
Dette totale / capitaux propres

The data points to relatively defensive market behavior.

Trading Data

50-Day MA: 105,29 €
200-Day MA: 110,06 €
Volume: 366,120
Avg. Volume: 512,336
Short Ratio: 3
P/B Ratio: 2.92x
Debt/Equity: 53.72x
Free Cash Flow: 221 M €

💵 Dividend Info

Dividend Yield
1.57%
Annual Rate
1,65 €
Payout Ratio
31.85%

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy AptarGroup, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Scroll to Top